Cycloheximide rapidly inhibits cortical COX activity and COX-dependent pial arteriolar dilation in piglets
1 Department of Physiology and Pharmacology, 2 Department of Pediatrics, and 3 Stroke Research Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1010; 4 Department of Physiology, Albert Szent-Györgyi Medical University, Szeged, H-6720 Hungary; and 5 Departme...
Gespeichert in:
Veröffentlicht in: | American journal of physiology. Heart and circulatory physiology 1999-09, Vol.277 (3), p.H1113-H1118 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | 1 Department of Physiology and
Pharmacology, 2 Department of
Pediatrics, and 3 Stroke Research
Center, Wake Forest University School of Medicine, Winston-Salem, North
Carolina 27157-1010; 4 Department
of Physiology, Albert Szent-Györgyi Medical University, Szeged,
H-6720 Hungary; and
5 Department of Anatomy and Cell
Biology, East Carolina University, School of Medicine, Greenville,
North Carolina 27858-4353
We have
previously shown that cycloheximide (CHX) preserved neuronal function
after global cerebral ischemia in piglets, in a manner similar
to indomethacin. To elucidate the mechanism of this protection, we
tested the hypothesis that CHX would inhibit cyclooxygenase (COX)
activity in the piglet cerebral cortex and vasculature. Pial arteriolar
responses to hypercapnia, arterial hypotension, and sodium
nitroprusside (SNP) were determined before and 20 min after treatment
with CHX (0.3-1 mg/kg iv) using a closed cranial window and
intravital microscopy. We also determined baseline and arachidonic acid
(AA)-stimulated cortical PGF 2
and 6-keto-PGF 1 production
before and 20-60 min after CHX (1 mg/kg iv) treatment, using ELISA
kits. CHX did not affect baseline diameters (~100 µm)
but significantly decreased arteriolar dilation to COX-dependent stimuli, such as hypercapnia and hypotension, but not to
COX-independent SNP. In the 1 mg/kg CHX-treated group, increases in
vascular diameters were reduced from 22 ± 2 to 10 ± 2%, from 49 ± 5 to 31 ± 3% (means ± SE, 5 and 10%
CO 2 , respectively,
n = 8), from 12 ± 3 to 3 ± 1%, and from 26 ± 5 to 6 ± 2% (~25 and 40%
decreases in blood pressure, respectively,
n = 6). CHX also inhibited conversion of exogenous AA to both PGF 2
and 6-keto-PGF 1 ; for example, 20 min after CHX treatment 10 µg/ml AA-stimulated
PGF 2 concentrations in the
artificial cerebrospinal fluid decreased from 14.28 ± 3.04 to 5.90 ± 1.26 ng/ml ( n = 9). Thus CHX
rapidly decreases COX activity in the piglet cerebral cortex. This
result may explain in part the preservation of neuronal function of CHX
in cerebral ischemia.
cerebral blood flow; arachidonic acid; hypercapnia; arterial
hypotension; prostaglandin H synthase |
---|---|
ISSN: | 0363-6135 0002-9513 1522-1539 |
DOI: | 10.1152/ajpheart.1999.277.3.H1113 |